These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19926100)

  • 1. Re: Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population: D. P. Ankerst, R. Miyamoto, P. V. Nair, B. H. Pollock, I. M. Thompson and D. J. Parekh J Urol 2009; 181: 2071-2076.
    Hammond I; Bunting PS
    J Urol; 2010 Jan; 183(1):396. PubMed ID: 19926100
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: It's time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer: I. M. Thompson, D. P. Ankerst, R. Etzioni and T. Wang J Urol 2008; 180: 1219-1222.
    Walsh PC
    J Urol; 2009 Mar; 181(3):1499; author reply 1499-500. PubMed ID: 19157429
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy I. M. Thompson, C. M. Tangen, D. P. Ankerst, C. Chi, M. S. Lucia, P. Goodman, H. Parnes and C. A. Coltman, Jr. J Urol 2008; 180: 544-547.
    Atmaca AF; Balbay MD
    J Urol; 2009 May; 181(5):2387-8. PubMed ID: 19303084
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Prospective evaluation of operating characteristics of prostate cancer detection biomarkers: Y. Liang, D. P. Ankerst, N. S. Ketchum, B. Ercole, G. Shah, J. D. Shaughnessy, Jr., R. J. Leach and I. M. Thompson J Urol 2011; 185: 104-110.
    Catalona WJ
    J Urol; 2011 Nov; 186(5):2131-2; author reply 2132. PubMed ID: 21945513
    [No Abstract]   [Full Text] [Related]  

  • 5. Why do I need a prostate exam when my PSA levels are normal?
    Mayo Clin Health Lett; 2006 Apr; 24(4):8. PubMed ID: 16649264
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above: A. Vickers, E. A. Vertosick, D. D. Sjoberg, M. J. Roobol, F. Hamdy, D. Neal, A. Bjartell, J. Hugosson, J. L. Donovan, A. Villers, S. Zappala and H. Lilja J Urol 2017;197:607-613.
    Shah N; Ioffe V
    J Urol; 2017 Aug; 198(2):445-446. PubMed ID: 28457843
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. S. E. Eggener, K. A. Roehl, O. Yossepowitch and W. J. Catalona, J Urol 2006; 176: 1399-1403.
    Wagner MD; Daneshmand S; Sokoloff M; Barry JM
    J Urol; 2007 Jun; 177(6):2396; author reply 2396-7. PubMed ID: 17509368
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. S. J. Freedland, E. A. Platz, J. C. Presti Jr., W. J. Aronson, C. L. Amling, C. J. Kane and M. K. Terris. J Urol, 175: 500-504, 2006.
    Stamatiou K; Alevizos A; Mariolis A; Sofras F
    J Urol; 2006 Sep; 176(3):1251-2; author reply 1252. PubMed ID: 16890735
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer: S. Loeb, M. G. Sanda, D. L. Broyles, S. S. Shin, C. H. Bangma, J. T. Wei, A. W. Partin, G. G. Klee, K. M. Slawin, L. S. Marks, R. H. N. van Schaik, D. W. Chan, L. J. Sokoll, A. B. Cruz, I. A. Mizrahi and W. J. Catalona J Urol 2015;193:1163-1169.
    Shah N; Ioffe V
    J Urol; 2015 Dec; 194(6):1825-6. PubMed ID: 26354886
    [No Abstract]   [Full Text] [Related]  

  • 10. Defining prostate cancer risk before prostate biopsy.
    Pal RP; Maitra NU; Mellon JK; Khan MA
    Urol Oncol; 2013 Nov; 31(8):1408-18. PubMed ID: 22795499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.
    Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Parnes HL; Lippman SM; Coltman CA
    J Urol; 2007 May; 177(5):1749-52. PubMed ID: 17437804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
    Hattangadi JA; Chen MH; D'Amico AV
    BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge, attitude and practice regarding prostate specific antigen (PSA) and prostate biopsy.
    Nazim SM; Raza SJ; Ather MH
    J Coll Physicians Surg Pak; 2013 Jul; 23(7):529-30. PubMed ID: 23823969
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: prostate specific antigen decrease and prostate cancer diagnosis: antibiotic versus placebo prospective randomized clinical trial: R. M. Stopiglia, U. Ferreira, M. M. Silva, W. E. Matheus, f. Denardi and L. O. Reis J Urol 2010; 183: 940-945.
    Yoon DK; Park HS; Park JY
    J Urol; 2010 Nov; 184(5):2214-5; author reply 2215. PubMed ID: 20864135
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of low prostate specific antigen on prostate cancer--a rare case report.
    Schneider HB
    Eur J Med Res; 2007 Jul; 12(7):311-3. PubMed ID: 17933704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The revival of the digital rectal exam?].
    Nau JY
    Rev Med Suisse; 2012 Apr; 8(337):866-7. PubMed ID: 22594012
    [No Abstract]   [Full Text] [Related]  

  • 17. [Elevated PSA--what to do?].
    Machemer H; Rohde D
    MMW Fortschr Med; 2008 Oct; 150(44):38-9. PubMed ID: 19024490
    [No Abstract]   [Full Text] [Related]  

  • 18. [Is it time to abandon the digital rectal examination?].
    Alcántara Montero A; Brenes Bermúdez FJ;
    Semergen; 2017; 43(8):593-594. PubMed ID: 28215992
    [No Abstract]   [Full Text] [Related]  

  • 19. Is routine digital rectal examination required for the followup of prostate cancer?
    Warren KS; McFarlane JP
    J Urol; 2007 Jul; 178(1):115-9. PubMed ID: 17499293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.